Last updated: 1 June 2019 at 12:35am EST

Ventures Fund Iv General Pa... Net Worth




The estimated Net Worth of Ventures Fund Iv General Pa... is at least $4.52 millió dollars as of 13 May 2019. Ventures Pa owns over 500,000 units of Axcella Health Inc stock worth over $4,515,985 and over the last 6 years Ventures sold AXLA stock worth over $0.

Ventures Pa AXLA stock SEC Form 4 insiders trading

Ventures has made over 1 trades of the Axcella Health Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Ventures bought 500,000 units of AXLA stock worth $10,000,000 on 13 May 2019.

The largest trade Ventures's ever made was buying 500,000 units of Axcella Health Inc stock on 13 May 2019 worth over $10,000,000. On average, Ventures trades about 500,000 units every 0 days since 2019. As of 13 May 2019 Ventures still owns at least 986,023 units of Axcella Health Inc stock.

You can see the complete history of Ventures Pa stock trades at the bottom of the page.



Insiders trading at Axcella Health Inc

Over the last 6 years, insiders at Axcella Health Inc have traded over $32,393 worth of Axcella Health Inc stock and bought 29,966,648 units worth $79,278,835 . The most active insiders traders include Ventures Fund Iv General Pa..., Ventures Fund Iv General Pa... és Des Produits Nestle S.A.Nes.... On average, Axcella Health Inc executives and independent directors trade stock every 31 days with the average trade being worth of $3,073,698. The most recent stock trade was executed by Margaret Koziel on 1 March 2023, trading 679 units of AXLA stock currently worth $394.



What does Axcella Health Inc do?

axcella has pioneered a new therapeutic class – defined amino acid compositions (daacs™). our daac therapeutics leverage the essential signaling function of amino acids to restore health across a network of dysregulated pathways, and provide safer solutions for patients with complex disease. with our axcellerator™ platform, we are transforming traditional drug discovery and development by generating patient data in less than a year from indication selection. this platform has delivered a rich pipeline including clinical programs in liver, metabolic, cns and orphan diseases.



Complete history of Ventures Pa stock trades at Axcella Health Inc

Az érdekelt
Trans.
Tranzakció
Teljes ár
Ventures Fund Iv General Pa...
Megvenni $10,000,000
13 May 2019


Axcella Health Inc executives and stock owners

Axcella Health Inc executives and other stock owners filed with the SEC include: